A Phase II, Open-Label, Multi-Center Prospective, Conversion Study in Stable Kidney Transplant Patients to Compare the Pharmacokinetics of LCP-Tacro Tablets Once-A-Day to Prograf Capsules Twice-A-Day
Phase of Trial: Phase II
Latest Information Update: 08 Apr 2017
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- Sponsors Veloxis Pharmaceuticals
- 08 Apr 2017 Results of a population pharmacokinetic model based on data from this and other study (NCT00608244), published in the Clinical Pharmacokinetics.
- 03 Mar 2008 Top-line results reported in a LifeCycle Pharma media release.
- 28 Jan 2008 Status change from in progress to completed as reported by clinicaltrials.gov.